Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Viatris Takes Over 14 Off-Patent Drugs, 4 AGs from Pfizer
September 3, 2021
- Reed Maurer, First Japan Representative for PhRMA, Dies at 83
September 3, 2021
- Takeda’s Pevonedistat Misses Primary Goal in PIII for MDS, MML, AML
September 3, 2021
- Astellas Pauses AT132 Gene Therapy Trial after Serious Adverse Event
September 2, 2021
- Kyowa to Resume Alfacalcidol Shipments in Mid-Sept.; MHLW Urges Priority for Patients without Alternative Therapies
September 2, 2021
- Takeda Recalling Suspended Batches of Moderna Jabs in Japan; Administrative Action Possible
September 2, 2021
- MSD Urges Govt to Start HPV Vaccine Discussions as Soon as Possible
September 2, 2021
- SymBio, Singapore’s National Cancer Centre Tie Up to Investigate Brincidofovir’s Anti-Tumor Activity
September 2, 2021
- Former Novartis Japan Chair Masao Torii Tapped as Fronteo’s Strategic Advisor
September 2, 2021
- NanoCarrier’s Otitis Media Treatment Smashes Primary Endpoints in Japan PIII
September 2, 2021
- Kyowa Kirin Files Automated-Injection Device of G-Lasta in Japan
September 2, 2021
- Acetaminophen Prescribed to Over 3 Million Patients in July due Possibly to COVID-19 Vaccine Reactions: Survey
September 1, 2021
- Sawai’s Rising Shipment Controls Now Hit 420 Products
September 1, 2021
- Lilly, Daiichi Sankyo Tie Up on Another Migraine Drug in Japan
August 31, 2021
- Lixiana Hits Goal in High-Risk AF Patients after Heart Valve Procedure
August 31, 2021
- Alnylam’s 2nd siRNA Therapy Givlaari Hits Japan Market
August 31, 2021
- Santen Files Diquas Follow-Up for Dry Eye in Japan
August 31, 2021
- Otsuka Launches Migraine Drug Ajovy in Japan
August 31, 2021
- Tagrisso Filed in Japan for Adjuvant Therapy in EGFR NSCLC
August 31, 2021
- Active Investments in Biotech Upstarts Needed to Create Healthcare Ecosystems: Shonan iPark Manager
August 30, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…